Terry L. Murdock, Chief Operating Officer at G1 Therapeutics, Inc. (GTHX), sold 2,368 shares at $5.58 ($13K) on 2023-01-04, disclosed to the SEC on 2023-01-05.
Open-market sale of $13k GTHX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.58 | 1,639 | $9K | 69.9% |
| 2 | $5.41 | 729 | $4K | 30.1% |
| Total | $5.53 avg | 2,368 | $13K | 100% |
| Filing → |
| GTHX | SELL | 2024-01-08 | $12K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $3K | — | Filing → |
| GTHX | SELL | 2022-07-06 | $3K | — | Filing → |